Results 51 to 60 of about 346,921 (314)

Toyota Prius Plug-In HEV: A Plug-In Hybrid Electric Car in NREL's Advanced Technology Vehicle Fleet (Fact Sheet)

open access: yes, 2011
This fact sheet highlights the Toyota Prius plug-in HEV, a plug-in hybrid electric car in the advanced technology vehicle fleet at the National Renewable Energy Laboratory (NREL).

core   +1 more source

Intelligent Autonomous Decision-Making and Cooperative Control Technology of High-Speed Vehicle Swarms [PDF]

open access: yes, 2022
This book is a reprint of the Special Issue “Intelligent Autonomous Decision-Making and Cooperative Control Technology of High-Speed Vehicle Swarms”,which was published in Applied ...

core   +1 more source

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang   +12 more
wiley   +1 more source

Influence of printing direction on 3D printed ABS specimens

open access: yesProduction Engineering Archives, 2020
In the recent years, additive manufacturing became an interesting topic in many fields due to the ease of manufacturing complex objects. However, it is impossible to determine the mechanical properties of any additive manufacturing parts without testing ...
Markiz Nassim   +2 more
doaj   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Representative road selection and route planning for commercial vehicle development

open access: yes, 2022
S.117-128Measuring loads for durability as well as emission and consumption for drivetrain assessment on public roads are indispensable parts of the commercial on-road vehicle development.
Wagner, B.   +4 more
core   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Commercial Vehicle Technology 2020/2021. 6th Commercial Vehicle Technology Symposium. Proceedings

open access: yes, 2022
Die Beiträge des Bandes Commercial Vehicle Technology 2020/2021 sind eine Sammlung von Publikationen für das 6. CVT Symposium der Commercial Vehicle Alliance Kaiserslautern.

core  

The effect of current military maintenance practices and regulations on the implementation of Integrated Vehicle Health Management technology [PDF]

open access: yes, 2012
Health monitoring tools can be used to diagnose failures and estimate the remaining useful life of certain components, generating information that can be used to improve the management of logistics and maintenance activities in what is known as ...
Esperon Miguez, Manuel   +2 more
core   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy